Innovative FEED Act of 2025
- Bill Number
- S. 1906
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-05-22: Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
- Last Updated
- 2026-04-08T15:24:02Z
AI-Generated Summary
Purpose
The Innovative Feed Enhancement and Economic Development Act of 2025 (Innovative FEED Act) aims to update the Federal Food, Drug, and Cosmetic Act (FD&C Act) by creating a clear regulatory framework for "zootechnical animal food substances." These are innovative additives intended to improve animal digestion, reduce harmful bacteria in food animals, or modify gut bacteria without acting like traditional drugs. The goal is to encourage the development of safer, more efficient animal feeds while distinguishing them from animal drugs to avoid overly strict drug-approval processes.
Key Provisions
- Definition of Zootechnical Animal Food Substances (amends Section 201 of the FD&C Act):
- Substances added to animal food or water that target the digestive process, reduce foodborne pathogens (like bacteria that can harm humans from animal products), or alter the animal's gut microbiome (the community of microbes in the intestines) to affect body structure or function—excluding basic nutrition.
- Must act only within the animal's gastrointestinal tract (digestive system).
- Exclusions: Not applicable to substances for diagnosing, treating, or preventing animal diseases; hormones; certain approved or investigated animal drugs; ionophores (a type of antibiotic-like compound); or other items the Secretary of Health and Human Services (via the FDA) excludes through public rulemaking.
- These substances are classified as food additives (requiring safety approval under Section 409) but explicitly not as drugs, even if they have body-affecting effects.
- Approval Process for Food Additives (amends Section 409):
- Petitions for approval must include data on intended effects, required dosage, and full investigation reports on methods and controls.
- FDA regulations must specify safe use conditions, including how to achieve the intended effect.
- Approval can be denied if the substance fails to demonstrate its intended effect under proposed use conditions.
- Labeling requirements: Must include a statement that it is "Not for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals." Allowed to include claims about effects on animal body structure or function (per the definition).
- Misbranded Food (amends Section 403):
- Zootechnical substances without the required "not for disease" labeling statement are considered misbranded (illegally labeled), making them subject to enforcement actions.
- Rule of Construction:
- Does not authorize the FDA to mandate the use of any such substances or food additives.
Significant Changes to Existing Law
- Introduces a new subcategory of food additives specifically for zootechnical substances, which were previously unclear—potentially treated as unregulated, drugs, or general additives.
- Shifts regulatory oversight from drug-like scrutiny (under Sections 512 or 571 of the FD&C Act, which involve lengthy clinical trials for safety and efficacy) to the food additive pathway (Section 409), which focuses on safety but now also requires proof of intended non-nutritive effects.
- Adds tailored petition and labeling rules, preventing these substances from being misclassified as drugs solely due to their physiological effects.
- Empowers the FDA to exclude certain substances via public notice-and-comment rulemaking (a process where proposed rules are published for public input before finalizing).
Potential Impacts
- On Government Agencies: The FDA gains clearer authority to regulate these substances efficiently as food additives, potentially reducing workload from drug misclassifications but increasing it for new rulemaking and reviews. This could streamline approvals for innovative products.
- On Citizens and Industry: Animal agriculture (e.g., livestock farming) may benefit from faster access to feeds that improve animal health and reduce pathogens, leading to safer meat/dairy for consumers and lower production costs. However, stricter labeling could raise compliance expenses for manufacturers.
- On International Relations: Minimal direct impact, but could align U.S. standards with global trends in animal feed innovation, potentially aiding exports of U.S. agricultural products by demonstrating robust safety oversight.
Main Stakeholders Affected
- Animal Feed Manufacturers and Innovators: Primary beneficiaries, as the bill facilitates approval of new products without drug-level hurdles, spurring research and economic growth in the feed sector.
- Farmers and Livestock Producers: Gain access to targeted additives that enhance animal efficiency and food safety, potentially reducing disease risks and improving profitability.
- Veterinarians and Animal Health Professionals: Affected by labeling rules that clarify non-medical uses, preventing misuse as treatments.
- Consumers and Public Health Advocates: Indirectly impacted through safer animal-derived foods (e.g., less pathogen risk in meat), though reliance on FDA oversight is key.
- FDA and Regulators: Responsible for implementing definitions, reviews, and enforcement, with added flexibility but also accountability for public rulemaking.
Notable Legal, Constitutional, or Political Implications
- Legal: Clarifies boundaries between food additives and drugs under the FD&C Act, reducing ambiguity that could lead to lawsuits over misclassification. The emphasis on safety and efficacy proof strengthens FDA's enforcement tools without expanding its mandate.
- Constitutional: No direct challenges; aligns with Congress's authority to regulate interstate commerce (including food safety) under the Commerce Clause. The rulemaking provision respects due process by requiring public input.
- Political: Bipartisan support (introduced by senators from both parties with agricultural interests) signals intent to boost rural economies and innovation in farming, potentially influencing future farm bills. It promotes a pro-innovation stance without deregulating safety, avoiding controversy over public health risks.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (7)
Sen. Baldwin, Tammy [D-WI], Sen. Moran, Jerry [R-KS], Sen. Bennet, Michael F. [D-CO], Sen. Grassley, Chuck [R-IA], Sen. King, Angus S., Jr. [I-ME], Sen. Klobuchar, Amy [D-MN], Sen. Collins, Susan M. [R-ME]
Recent Actions
- 2025-05-22: Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
- 2025-05-22: Introduced in Senate
Bill Versions
- Innovative Feed Enhancement and Economic Development Act of 2025 — issued 2025-05-22 — PDF (7 pages)